HIV infection and AIDS in the public health and health care systems - The role of law and litigation

被引:22
作者
Gostin, LO
Webber, DW
机构
[1] Georgetown Johns Hopkins Program Law & Publ Hlth, Washington, DC USA
[2] Georgetown Johns Hopkins Program Law & Publ Hlth, Baltimore, MD USA
来源
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION | 1998年 / 279卷 / 14期
关键词
D O I
10.1001/jama.279.14.1108
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The AIDS Litigation Project has reviewed nearly 600 reported cases involving individuals with human immunodeficiency virus (HIV) infection and acquired immunodeficiency syndrome (AIDS) in the federal and state courts in the United States between 1991 and 1997. Cases were identified through a federal and 50-state computer and library search. An important subset of litigation relates to HIV/AIDS in the public health and health care systems, since the law affects health care institutions and professionals, patients, and public health policy in America. This subset of HIV/AIDS litigation includes testing and reporting; privacy, the duty to warn, and the right to know; physician standards of care in prevention and treatment; and discrimination and access to health care. In broad terms, the review demonstrates a reliance on voluntary testing and protection of patient privacy through HIV-specific statutes and the common law. Negligence with potential civil and criminal liability has been alleged in cases of erroneous or missed diagnosis of HIV infection. In the first AIDS case to be considered by the Supreme Court, the Court will decide whether patients with asymptomatic HIV infection are protected under the Americans with Disabilities Act. Considerable progress has been made, both socially and legally, during the first 2 decades of the epidemic, but much still needs to be accomplished to protect privacy, prevent discrimination, and promote tolerance.
引用
收藏
页码:1108 / 1113
页数:6
相关论文
共 28 条
[1]  
[Anonymous], 1991, MMWR Recomm Rep, V40, P1
[3]   The legal strategies used in operating syringe exchange programs in the United States [J].
Burris, S ;
Finucane, D ;
Gallagher, H ;
Grace, J .
AMERICAN JOURNAL OF PUBLIC HEALTH, 1996, 86 (08) :1161-1166
[4]  
Burris Scott, 1992, Univ Miami Law Rev, V47, P291
[5]   Antiretroviral therapy for HIV infection in 1997 - Updated recommendations of the International AIDS Society USA panel [J].
Carpenter, CCJ ;
Fischl, MA ;
Hammer, SM ;
Hirsch, MS ;
Jacobsen, DM ;
Katzenstein, DA ;
Montaner, JSG ;
Richman, DD ;
Saag, MS ;
Schooley, RT ;
Thompson, MA ;
Vella, S ;
Yeni, PG ;
Volberding, PA .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1997, 277 (24) :1962-1969
[6]  
*CDC, 1985, MMWR-MORBID MORTAL W, V34, P1
[7]  
*CDCP, 1997, MMWR-MORBID MORTAL W, V46, P861
[8]  
Centers for Disease Control and Prevention, 1997, HIV PREV B MED ADV P
[9]  
*EEOC, 1993, EEOC INT GUID APPL A
[10]  
Fiscus SA, 1996, JAMA-J AM MED ASSOC, V275, P1483, DOI 10.1001/jama.275.19.1483